Omega Funds founder and managing director Otello Stampacchia isn’t afraid to tell it like he sees it.

The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.

Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

Learn more about whether Alvotech or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

BioPharma Credit (LSE: BPCR) is one of the more esoteric investment trusts listed in London. Biotech is a specialist sector ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to ...

Schroder Investment Management Group lifted its holdings in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free ...